Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |